Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Azenta, Inc.AZTA · Entity 4724 | SVP and GM, Multiomics | November 24, 2025 | November 26, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Azenta, Inc.
Report date November 24, 2025 · Filed November 26, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CommonSEC Table I · non-derivative | Direct | 38,755 |
Reported balance
After 2025-11-24 transaction · row 1
1 source rowRow 1 · 2025-11-24 · Grant · Acquired 13,042 · Balance 38,755 F1: Represents the grant of restricted stock units ("RSUs"). No amount was paid upon grant of the RSUs. The number of RSUs granted was determined by dividing the target award value by the average closing price of the Company's common stock over the 20 trading days ending on the date of grant. The RSUs are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 24, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the grant of restricted stock units ("RSUs"). No amount was paid upon grant of the RSUs. The number of RSUs granted was determined by dividing the target award value by the average closing price of the Company's common stock over the 20 trading days ending on the date of grant. The RSUs are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 24, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 24, 2025 Filed Nov 26, 2025 01:15 UTC | Azenta, Inc. AZTA · Entity 4724 | GrantCommon | 13,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-297830 · ownership.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and GM, Multiomics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,755 F1 · shares: Represents the grant of restricted stock units ("RSUs"). No amount was paid upon grant of the RSUs. The number of RSUs granted was determined by dividing the target award value by the average closing price of the Company's common stock over the 20 trading days ending on the date of grant. The RSUs are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 24, 2026. Read SEC document |
| November 14, 2025 Filed Nov 17, 2025 21:54 UTC | Azenta, Inc. AZTA · Entity 4724 | Tax withholdingCommon | 1,118 | $29.75 | $33,260.50 |
DisclosureSEC source: 0001193125-25-284747 · ownership.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and GM, Multiomics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,713 F1 · shares: The withholding of shares from the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2025 of 4,582 restricted stock units held by the reporting person. Read SEC document |
| August 12, 2025 Filed Aug 13, 2025 20:47 UTC | Azenta, Inc. AZTA · Entity 4724 | Disposition to issuerCommon | 1,085 | $28.54 | $30,965.90 |
DisclosureSEC source: 0000950170-25-108118 · ownership.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and GM, Multiomics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,831 F1 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on August 9, 2025 of 3,167 restricted stock units held by the reporting person. Read SEC document |
| August 12, 2025 Filed Nov 14, 2025 21:10 UTC Amendment | Azenta, Inc. AZTA · Entity 4724 | SaleCommon | 1,085 | $28.54 | $30,965.90 |
DisclosureSEC source: 0001193125-25-282944 · ownership.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and GM, Multiomics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,831 F1 · date: This amendment is being filed to include the Power of Attorney authorizing the undersigned to sign and file Forms 3, 4, and 5 on behalf of the reporting person, which was inadvertently not included with the original Form 4 filed on August 13, 2025. F2 · kind: This amendment is being filed to correct an administrative error in the transaction code reported in the original Form 4 filed on August 13, 2025. The transaction was inadvertently reported using transaction code "D" instead of the correct code "S." Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 21:10 UTC | Azenta, Inc. AZTA · Entity 4724 | PurchaseCommon | 417 | $45.88 | $19,131.96 |
DisclosureSEC source: 0000950170-25-013428 · ownership.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,916 F1 · shares: Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 21:10 UTC | Azenta, Inc. AZTA · Entity 4724 | SaleCommon | 491 | $40.07 | $19,674.37 |
DisclosureSEC source: 0000950170-24-129722 · ownership.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,499 F1 · shares: Represents the sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2024 of 1,844 restricted stock units from three grants held by the reporting person and previously reported on Form 4. F2 · price: Represents the weighted average price for shares sold between November 18, 2024 and November 19, 2024 at a range between $38.83 and $41.48. The reporting person will provide to the Securities and Exchange Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 21:10 UTC | Azenta, Inc. AZTA · Entity 4724 | GrantCommon | 8,651 | $41.51 | $359,103.01 |
DisclosureSEC source: 0000950170-24-128586 · ownership.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,990 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2025. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 20:10 UTC | Azenta, Inc. AZTA · Entity 4724 | GrantCommon | 6,333 | $55.27 | $350,024.91 |
DisclosureSEC source: 0000950170-24-096202 · ownership.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,339 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units.The units will vest over two years, 50% on August 9, 2025 and 50% on August 9, 2026. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:10 UTC | Azenta, Inc. AZTA · Entity 4724 | GrantCommon | 448 | $39.41 | $17,655.68 |
DisclosureSEC source: 0000950170-24-010489 · ownership.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,942 F1 · shares: Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act Read SEC document |
| January 31, 2024 Filed Aug 2, 2024 20:05 UTC | Azenta, Inc. AZTA · Entity 4724 | GrantCommon | 64 | $53.01 | $3,392.64 |
DisclosureSEC source: 0000950170-24-089938 · ownership.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,006 F1 · shares: Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 21:14 UTC | Azenta, Inc. AZTA · Entity 4724 | GrantCommon Stock | 3,207 | $54.57 | $175,005.99 |
DisclosureSEC source: 0001209191-23-055732 · doc4.xml · nonDerivative · entry 3 Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,494 F3 · shares: Grant of restricted stock units to the Reporting Person under the Company's Long Term Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2024. Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 21:14 UTC | Azenta, Inc. AZTA · Entity 4724 | Disposition to issuerCommon Stock | 458 | $53.81 | $24,644.98 |
DisclosureSEC source: 0001209191-23-055732 · doc4.xml · nonDerivative · entry 2 Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,287 F2 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2023 of 877 performance stock units and 970 of restricted stock units held by the reporting person. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:14 UTC | Azenta, Inc. AZTA · Entity 4724 | GrantCommon Stock | 877 | $54.13 | $47,472.01 |
DisclosureSEC source: 0001209191-23-055732 · doc4.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,745 F1 · shares: Represents shares issued upon the vesting of performance-based units granted on November 13, 2020, of which one-third was determined to be earned at 150% and converted into restricted stock units which vested on November 15, 2023. No amount was paid by the reporting person upon grant or vesting of the performance-based units. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 20:10 UTC | Azenta, Inc. AZTA · Entity 4724 | GrantCommon Stock | 54 | $39.98 | $2,158.92 |
DisclosureSEC source: 0001209191-23-043947 · doc4.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,868 F1 · shares: Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:10 UTC | Azenta, Inc. AZTA · Entity 4724 | GrantCommon Stock | 323 | $46.92 | $15,155.16 |
DisclosureSEC source: 0001209191-23-006194 · doc4.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,814 F1 · shares: Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:27 UTC | Azenta, Inc. AZTA · Entity 4724 | GrantCommon Stock | 1,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058149 · doc4.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,491 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Long Term Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2023. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:21 UTC | Azenta, Inc. AZTA · Entity 4724 | Tax withholdingCommon Stock | 680 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057544 · doc4.xml · nonDerivative · entry 2 Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,602 F2 · shares: The forfeiture of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2022 of 2,236 performance stock units and 544 of restricted stock units held by the reporting person. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:21 UTC | Azenta, Inc. AZTA · Entity 4724 | GrantCommon Stock | 2,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057544 · doc4.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,282 F1 · shares: Represents shares issued upon the vesting of performance-based units granted on November 11, 2019, which were subject to performance-based vesting requirements measured at the three-year period ended September 30, 2022. No amount was paid by the reporting person upon grant or vesting of the performance-based units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.